GLP-1 Peptides: A Different Set of Risks GLP-1 drugs are the one group with a real evidence base: no known dangerous interaction with alcohol, and labels do not forbid drinking
The risk of two carriers passing the abnormal gene to an affected child is 25%
The evidence for their effectiveness remains mixed, particularly in healthy individuals, and their long-term impact remains largely unknown
Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study
Every night of poor sleep is a night of missed recovery, missed repair, and missed restoration
Having a healthcare team that has been selected by the patient and who provides the care that they need and find effective, can drastically change someone's experience